BVT Aktienanleihe FRE 28.03.2025/ DE000VD1TW13 /
10/01/2025 08:41:04 | Chg.+0.02 | Bid13:09:43 | Ask13:09:43 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.72EUR | +0.02% | 100.71 Bid Size: 500,000 |
100.81 Ask Size: 500,000 |
FRESENIUS SE+CO.KGAA... | 21.00 - | 28/03/2025 | Call |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil